Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Exec appointment
confidence 95%
filed 2026-10-21
Item 5.02
Robin Swartz was appointed President of Voyager Therapeutics effective October 20, 2026, and is expected to succeed Alfred W. Sandrock, Jr. as CEO following receipt of initial safety data in Q1 2027. This is a material executive appointment involving a clear succession plan for the chief executive role. While the disclosure also includes compensatory arrangements (equity grants, salary, severance terms), the principal disclosed action centers on Swartz taking on the President role with anticipated CEO succession, making exec_appointment the most salient classification.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-10-21
Item 5.02
John M. Boushy was appointed as a Class II Director of Galaxy Gaming effective October 21, 2026. Boushy is a distinguished gaming industry executive with 45+ years of experience and significant prior roles at Harrah's, Ameristar, and Caesars. The appointment also coincided with the resignation of Meredith Brill from the Board effective October 20, 2026.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-10-21
Item 5.02
Michael D. Fertitta was appointed as a director effective immediately following the closing of the Savage Arms acquisition, with the Board expanding to seven directors. The appointment reflects investor rights tied to JDH Capital's 16.7% ownership stake resulting from the acquisition and includes service on the Nominations and Corporate Governance Committee.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-10-21
VTEX announced the appointment of Leandro Balbinot to its Board of Directors, effective November 1, 2026. Balbinot is a seasoned executive with three decades of experience in technology and retail leadership at major companies including Amazon, Capital One, and McDonald's. Board appointments are material governance events that affect the registrant's leadership and strategic direction.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-10-21
Item 5.02
Ms. Lori Anello was appointed by the Board of Managers of the Managing Owner to serve as Principal Financial and Accounting Officer of Invesco Capital Management LLC, effective October 22, 2026. While the disclosure also mentions Ms. Kelli Gallegos beginning a leave of absence, the principal action disclosed is the appointment of Anello to a key financial officer role. The appointment of a Principal Financial and Accounting Officer is material to investors as it affects the fund's financial oversight and reporting.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-10-21
Item 5.02
Ms. Lori Anello was appointed as Principal Financial and Accounting Officer of Invesco Capital Management LLC (the Sponsor) effective October 22, 2026, following Ms. Kelli Gallegos's leave of absence. The appointment of a Principal Financial and Accounting Officer—a key financial leadership role—is material to investors' assessment of the fund's governance and financial oversight. While the filing also discloses a departure (Gallegos's leave), the principal disclosed action centers on Anello's appointment to this critical officer position.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-10-21
Item 5.02
The filing discloses the appointment of Nigel Dawn and Naveen Nataraj as Co-Presidents of Evercore, effective January 1, 2027, representing a material promotion of two senior executives to newly created leadership roles reporting directly to the CEO. While the disclosure also includes compensatory arrangements (PRSUs worth $20 million each), the principal disclosed action centers on the appointment itself, which materially affects the firm's senior leadership structure and succession planning.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-10-21
Item 5.02
The filing discloses the appointment of Christopher Garcia as Executive Vice President, General Counsel and Secretary (chief legal officer) effective February 1, 2027, following Richard Rothberg's announced retirement. While both a departure and appointment occur, the principal disclosed action centers on Garcia's appointment to a C-suite legal role, making exec_appointment the most salient classification. This is material as it involves succession planning for a senior executive position responsible for legal and governance functions.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-10-21
Item 5.02
Mattel appointed Lee Matheson, a Partner at EdgePoint Investment Group (an ~18% shareholder), to its Board of Directors effective October 21, 2026, increasing board size from nine to ten members. The appointment was made pursuant to a cooperation agreement with EdgePoint that includes voting commitments, standstill restrictions, and director replacement rights.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-10-21
Item 5.02
The Board appointed Geno J. Germano as a new director on October 19, 2026, increasing Board size from five to six members. Germano brings extensive pharmaceutical industry experience and public company board credentials.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-10-21
Item 8.01
The Company appointed T.R. Srinivas, M.D. to the position of Senior Vice President and Chief Medical Officer, a named executive role material to the Company's clinical and regulatory strategy.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-10-21
Item 7.01
The filing discloses the appointment of David Thomas as Senior Vice President of Project Development of Ambler Metals LLC, a 50/50 joint venture operating company. While the press release also announces completion of the 2026 field program, the principal executive action disclosed is the appointment of a senior officer to lead engineering and project development for the Arctic Project. The appointment is material given Thomas's extensive experience and his role in advancing the project toward a construction decision targeted for 2028.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-10-21
The filing discloses the appointment of Amy Shi as Executive Chair of the Board effective October 15, 2026. While the disclosure also includes compensatory arrangements (annual cash of $120,000 escalating to $240,000, equity award of $250,000 reference value, and severance provisions), the principal disclosed action is the appointment of Shi to an executive leadership role. The appointment of an Executive Chair is a material governance event affecting the registrant's leadership structure.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-10-21
The press release announces the appointment of David Hendriks as Chief Operating Officer and Ron Espell as Vice-President, Environment & Permitting. These are senior executive appointments at a development-stage mining company advancing two tungsten projects toward production. The COO appointment is particularly material given the company's stated focus on project development and the executive's extensive experience in mine construction and operations in Nevada.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-10-21
Item 5.02
The filing discloses both the departure of CEO George England and the appointment of Jean Jacques Sunier as CEO effective October 16, 2026. While both events occurred, the principal action disclosed is the appointment of a new Chief Executive Officer, with detailed background on Mr. Sunier's qualifications and prior roles. The departure is characterized as amicable with no disagreement, making the appointment the salient event. CEO changes are material to investors' assessment of company leadership and direction.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-10-20
Item 5.02
Northern Trust's Board appointed Rima Qureshi as a director effective October 20, 2026, and assigned her to the Risk Committee and Technology and Operations Committee. Qureshi is a seasoned C-suite executive with nearly four decades of experience and extensive public company board service, including former EVP and Chief Strategy Officer at Verizon and CEO of Ericsson North America.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-10-20
Item 5.02
The Board of Directors appointed Karin Risi as a director of Whirlpool Corporation effective immediately on October 19, 2026, with assignment to the Human Resources Committee and Finance Committee. This is a clear executive appointment event. While the disclosure also includes director compensation details (annual cash retainer of $150,000 and equity compensation of $160,000), the principal disclosed action is the appointment itself, not a compensation arrangement modification. The appointment of a new board member with significant asset management and governance experience is material to investors.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-10-20
Item 5.02
Daniel Brennan was appointed as a new member of the board of directors of Vertex Pharmaceuticals on October 20, 2026, with the board size increasing from ten to eleven members. While the disclosure also mentions a $400,000 restricted stock unit award, the principal disclosed action is the appointment itself. Brennan's extensive finance and healthcare background (former CFO of Boston Scientific, current board member at Waters and Madrigal Pharmaceuticals) and his assignment to the Audit and Finance Committee make this a material governance event affecting investor assessment of board composition and oversight.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-10-20
Item 5.02
Meyer "Micky" Malka was appointed to Apollo Global Management's Board of Directors, effective January 1, 2027, with the board size increasing to 14 directors. The appointment was announced via press release and is material to investors given its impact on board composition at the major alternative asset manager.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-10-20
Item 5.02
Insmed appointed two new independent directors effective October 19, 2026: Paul Hudson (former CEO of Sanofi and Novartis) and Utpal Koppikar (CFO of Verily Health). Both received committee assignments and equity compensation packages of approximately $585,000 in RSUs each, bringing significant executive experience to the board at a pivotal time for the company.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-10-20
Item 5.02
PDS Biotechnology appointed three new directors—Deborah A. Ramsdell, John A. Dawson CBE, and Bruce Wendel—to its Board of Directors effective October 18, 2026, bringing substantial pharma industry experience in drug development, commercialization, and M&A. The appointments occurred simultaneously with the resignation of four existing directors.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-10-20
Item 5.02
The filing discloses the appointment of Andrew Raab as a director of StubHub Holdings, Inc., effective October 16, 2026, to fill an existing vacancy on the Board. While the disclosure also mentions prior transactions (Series O preferred stock purchase and consulting agreement), the principal action disclosed in this Item 5.02 is the director appointment itself, which is material to investors as it affects board composition and governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-10-20
Item 5.02
Newell Brands announced the appointment of Guillermo H. Beade as Chief Operating Officer, effective October 26, 2026. The disclosure details his background, reporting relationship to the CEO, and comprehensive compensation package including base salary of $830,000, bonus eligibility, and long-term incentive participation. This is a material executive appointment to a senior operational role with enterprise accountability for sales, marketing, and supply chain functions globally.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-10-20
Item 5.02
Scott M. Wasserman, MD was appointed as a Class III director and member of the Compensation Committee effective October 19, 2026, bringing significant clinical development expertise to support the Company's Phase 3 IMPROVE-PAH study. The appointment includes equity compensation of 310,000 stock options. Dennis Berman's concurrent resignation is noted but secondary to the forward-looking appointment.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 92%
filed 2026-10-20
EX-99.1
The exhibit announces the appointment of Tim Cox as U.S. Country Head and CEO of BMO's U.S. subsidiaries, effective November 1, 2026, with a reporting line to the CEO and Executive Committee membership. While the announcement also mentions Darrel Hackett's transition to Executive Vice-Chair and Senior Advisor (a departure from his U.S. CEO role), the principal disclosed action is Cox's appointment to a material executive position overseeing BMO's U.S. operations. This is a significant leadership change at a major financial institution affecting governance and operational structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-10-20
Item 5.02
The Board of Directors appointed Gary Ferrera and Brian Krzanich as directors on October 14, 2026, expanding the board from seven to nine members. Both appointees bring substantial executive experience (Ferrera with 30+ years in financial leadership including multiple CFO roles; Krzanich with 40+ years in technology including CEO roles at three public companies), and Ferrera was appointed to the Audit Committee. This is a material governance event affecting board composition and oversight.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 85%
filed 2026-10-20
The 6-K discloses the appointment of Bekazela Matshazi as a director of Golden Sun Technology Group Limited, effective September 23, 2026, to fill a vacancy created by the resignation of Liming Xu. While the resignation is also mentioned, the principal disclosed action is the appointment of a new director to the board. Ms. Matshazi's concurrent role as Co-Chief Executive Officer elevates the materiality of this appointment to a reasonable investor.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-10-20
The filing discloses the appointment of Timothy A. Peterman as permanent Chief Financial Officer and Secretary of Laser Photonics Corporation, effective October 6, 2026, following his service as Acting CFO since September 8, 2026. Item 5.02 details his employment agreement with specific compensation terms ($300,000 base salary, equity awards, bonus structure, and severance provisions). While the filing also includes compensatory arrangement details, the principal disclosed action is Peterman's appointment to a permanent executive officer role, making exec_appointment the most salient classification.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-10-20
The filing discloses that Dan Golding was elected to Soluna's Board of Directors at the October 16, 2026 annual meeting of stockholders. The press release emphasizes his appointment as a board member, his 30+ years of data center experience including leadership at Google and Iron Mountain, and his prior service as an advisor since 2023. This is a clear executive appointment event material to investors assessing board composition and governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-10-20
Item 5.02
The Board of Directors elected C. Michael Petters, the former President and CEO, to the Board of Directors effective October 19, 2026, and appointed him to the Cybersecurity and Finance Committees. While the disclosure also includes compensatory arrangements (annual cash retainer of $130,000, committee retainers of $20,000 each, and annual equity grant of $195,000 in deferred stock units), the principal disclosed action is Petters taking a board role. This is material as it involves a former chief executive rejoining the board of a major defense contractor.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-10-20
Item 5.02
Suja Life appointed two independent directors, Robert B. Engel (former CoBank CEO with 45+ years in banking and accounting) and Zahir Ibrahim (former CFO of Annie's, KIND, and BARK with ~30 years in financial leadership), to its Board of Directors effective October 16, 2026. Engel was also appointed to the Audit Committee, and the Board size increased from seven to nine members.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-10-20
Item 5.02
Brett L.A. Manning was appointed Chief Business Officer of the Federal Home Loan Bank of Des Moines effective October 16, 2026, with responsibility for member-facing departments. While the disclosure includes compensatory details (base salary of $425,000 and incentive awards up to 80% of base), the principal disclosed action is the appointment of an executive officer to a new role, making exec_appointment the most salient classification. The appointment is material as it represents a significant leadership change in a key executive position.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-10-20
Item 5.02
Cristian Melej, a current board member, was appointed as Chief Financial Officer, principal financial officer, and principal accounting officer effective upon the filing of the 2026 10-K, bringing substantial CFO experience from prior roles including Hingham Institution for Savings since 2016.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-10-20
Item 8.01
Jennifer Holmgren, LanzaTech Global's Chief Executive Officer, was appointed interim Chief Executive Officer of LanzaJet in connection with the recapitalization transactions.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 85%
filed 2026-10-20
EX-99.1
The press release announces the appointment of Glenn Williams as Chief Executive Officer and Jeremy North as Chief Operating Officer, both effective upon Nasdaq commencement of trading on 22 October 2026. While the release also discloses Jack Kaye's transition from CEO to Chairman and Sir Eric Peacock's step-down as Chairman, the principal disclosed action is the appointment of two new senior executives to lead the company's operations and growth strategy. This is material to investors as it represents a significant leadership transition at a newly public company.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-10-20
EX-99.1
The press release announces the appointment of Jordan Quinn as Vice President of Exploration, effective immediately, succeeding Benjamin Kuzmich who is stepping down from that role. This is a clear executive appointment of a named officer to a material operational role at a mineral exploration company, particularly significant given Quinn's direct involvement in the recent Scooby Zone discovery at Laird Lake and his appointment timing coinciding with planned return of drilling operations.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-10-19
Item 5.02
The Board of Directors appointed Lynn Martin to serve as a director effective October 19, 2026. This is a clear executive appointment of a director to the company's board. Martin's extensive background as President of NYSE Group and her expertise in technology, data, capital markets, and corporate governance make this a material appointment that would affect a reasonable investor's assessment of the company's leadership and governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-10-19
Item 5.02
The filing discloses the appointment of Jared Fedele as Senior Vice President and Chief Financial Officer effective March 1, 2027, following a succession-planning process. While Jason Cardew's departure is also mentioned, the principal disclosed action centers on Fedele's appointment to a critical executive role. The filing includes detailed background on Fedele's 23-year tenure and qualifications, and describes his new compensation and severance arrangements under the Fedele Agreement, making the appointment the salient event.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-10-19
Item 5.02
Matrix Service Company appointed Dominic A. Savarino as Senior Vice President and Chief Financial Officer, effective November 6, 2026. The appointment includes compensatory arrangements comprising a base salary of $500,000, annual bonus eligibility at 75-150% of base, annual equity grants at 140% of base, and a special one-time equity grant of $450,000.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 96%
filed 2026-10-19
Item 5.02
Daniel E. Brown was appointed as President and Chief Executive Officer of Expand Energy Corporation, effective October 26, 2026, and concurrently elected to the Board. The appointment includes compensatory arrangements comprising a base salary of $1,000,000, annual bonus target of 125%, long-term incentive awards of $8,750,000 annually, and a make-whole equity award of approximately $15.65 million.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 80%
filed 2026-10-19
Item 5.02
Ball Corp appointed Carey Causey as President of Beverage Packaging North and Central America (effective immediately) and Scott A. Vail as President of Beverage Packaging EMEA (effective January 1, 2027), both to senior vice president roles leading major business units.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-10-19
Item 5.02
CarMax appointed Darren W. Woodell as Vice President, Controller and Chief Accounting Officer, effective November 11, 2026, assuming the principal accounting officer role from Enrique N. Mayor-Mora. The disclosure centers on the appointment of a named executive to a material officer position (principal accounting officer), making this an exec_appointment event. The compensation details provided are incidental to the primary action of taking the role.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 94%
filed 2026-10-19
Item 5.02
Robert E. Hoffman was appointed Chief Executive Officer of CytoDyn effective October 20, 2026, following Board approval on October 16, 2026, replacing Dr. Jacob Lalezari who transitioned to Head of Research and Translational Sciences. The appointment includes significant compensation changes, including a base salary increase to $525,000, bonus target increase to 50%, and a 2.5 million share option grant, representing a material executive leadership transition for the clinical-stage biopharmaceutical company.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-10-19
Item 5.02
Peter Griffith was appointed as Chief Financial Officer and board director of Mattel, effective October 20, 2026, with a comprehensive compensation package including a $1.3M base salary, $3.3M PSU award, $1.4M signing bonus, and other equity arrangements. The filing also discloses the departure of Paul Ruh, who will serve in an advisory role through year-end.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-10-19
Item 5.02
The filing discloses the appointment of Andrew J. Silver as Chief Financial Officer of CRISPR Therapeutics AG effective October 19, 2026, along with detailed employment terms including a $515,000 annual salary, 45% target bonus, and a 25,000 RSU grant. While the section also mentions the concurrent resignation of prior CFO Raju Prasad, the principal disclosed action centers on the appointment of the new CFO and his compensatory arrangements, making exec_appointment the most salient classification. This is material to investors as it involves a key executive officer position at a major biotechnology company.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-10-19
Item 5.02
Scott Morris, Co-Founder of Freshpet with over three decades of experience in building and scaling fresh food brands, was appointed as a Class I director to Once Upon a Farm's Board of Directors, effective immediately, increasing the Board from nine to ten members.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-10-19
Item 5.02
Tamara Fischer was appointed as a trustee (director) of Acadia Realty Trust effective October 19, 2026, and concurrently appointed to the Nominating and Corporate Governance Committee. Ms. Fischer brings substantial REIT industry experience as a former CEO and CFO of major REITs and most recently served as Executive Chairperson of National Storage Affiliates Trust.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-10-19
Item 5.02
Three independent directors—Joshua Cohen, Mark McKenna, and Dr. Michael Henderson—were appointed to the Board effective October 15, 2026, in connection with the Company's IPO, with assignments to the Audit and Compensation Committees.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-10-19
Item 5.02
The filing discloses the appointment of Anthony Evers as Fractional Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer effective October 19, 2026, following the termination of Luke McPherson on October 13, 2026. While both a departure and appointment occur, the principal disclosed action centers on the appointment of a new CFO/PFO/PAO to fill the vacancy, making exec_appointment the most salient classification. The appointment is material as it addresses a critical financial officer role at the company.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-10-19
EX-99.1
Mr. Stanford Ming Lin has been appointed as a member of the Board of Directors of TH International Limited. This is a clear executive appointment to the board, a governance event material to investors as it affects board composition and oversight. The biographical detail confirms his senior experience at major multinational corporations (RBI, Nestlé, Visa, Walmart) and prestigious educational credentials.
View raw filing on EDGAR →